Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.

Matsuda KM, Yoshizaki A, Kuzumi A, Fukasawa T, Ebata S, Miura S, Toyama T, Yoshizaki A, Sumida H, Asano Y, Oba K, Sato S.

Arthritis Res Ther. 2019 May 28;21(1):129. doi: 10.1186/s13075-019-1919-6.

2.

Effect of forced-air warming by an underbody blanket on end-of-surgery hypothermia: a propensity score-matched analysis of 5063 patients.

Sumida H, Sugino S, Kuratani N, Konno D, Hasegawa JI, Yamauchi M.

BMC Anesthesiol. 2019 Apr 9;19(1):50. doi: 10.1186/s12871-019-0724-8.

3.

Serum levels of human β-defensin 2: possible association with fibrosis and vasculopathy in patients with systemic sclerosis.

Kuzumi A, Yoshizaki A, Fukasawa T, Ebata S, Miura S, Yoshizaki A, Sumida H, Asano Y, Sato S.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):e272-e274. doi: 10.1111/jdv.15546. Epub 2019 Mar 28. No abstract available.

PMID:
30835873
4.

[Aiming to Next-generation for Japanese Society of Radiological Technology].

Sumida H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(11):I. doi: 10.6009/jjrt.2018_JSRT_74.11.I. Japanese. No abstract available.

5.

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study.

Sumida H, Asano Y, Tamaki Z, Aozasa N, Taniguchi T, Toyama T, Takahashi T, Ichimura Y, Noda S, Akamata K, Saigusa R, Miyazaki M, Kuwano Y, Yanaba K, Yoshizaki A, Sato S.

J Dermatol. 2018 Dec;45(12):1425-1433. doi: 10.1111/1346-8138.14669. Epub 2018 Oct 5.

PMID:
30289572
6.

Rapid alteration of serum interleukin-6 levels may predict the reactivity of i.v. cyclophosphamide pulse therapy in systemic sclerosis-associated interstitial lung disease.

Numajiri H, Yoshizaki A, Fukasawa T, Ebata S, Nakamura K, Yamashita T, Saigusa R, Miura S, Hirabayashi M, Yoshizaki A, Sumida H, Asano Y, Kazoe Y, Mawatari K, Kitamori T, Sato S.

J Dermatol. 2018 Oct;45(10):1221-1224. doi: 10.1111/1346-8138.14580. Epub 2018 Jul 27.

PMID:
30051925
7.

Gastroesophageal Reflux Disease-Related Disorders of Systemic Sclerosis Based on the Analysis of 66 Patients.

Matsuda R, Yamamichi N, Shimamoto T, Sumida H, Takahashi Y, Minatsuki C, Kodashima S, Ono S, Niimi K, Tsuji Y, Sakaguchi Y, Saito I, Kataoka Y, Asada-Hirayama I, Kakimoto H, Yakabi S, Takeuchi C, Matsumoto Y, Tamaki Z, Fujishiro M, Asano Y, Sato S, Koike K.

Digestion. 2018;98(4):201-208. doi: 10.1159/000489848. Epub 2018 Jul 25.

PMID:
30045036
8.

How to Improve the Conspicuity of Breast Tumors on Computed High b-value Diffusion-weighted Imaging.

Tamura T, Takasu M, Higaki T, Yokomachi K, Akiyama Y, Sumida H, Nagata Y, Awai K.

Magn Reson Med Sci. 2019 Apr 10;18(2):119-125. doi: 10.2463/mrms.mp.2018-0011. Epub 2018 Jul 13.

9.

[Differentiation between Hepatic Focal Lesions and Heterogenous Physiological Accumulations by Early Delayed Scanning in 18F-FDG PET/CT Examination].

Ushio A, Takauchi K, Kobayashi M, Abe N, Sumida H, Nagata Y, Awai K.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(6):556-562. doi: 10.6009/jjrt.2018_JSRT_74.6.556. Japanese.

10.

G-Protein Coupled Receptor 18 Contributes to Establishment of the CD8 Effector T Cell Compartment.

Sumida H, Cyster JG.

Front Immunol. 2018 Apr 4;9:660. doi: 10.3389/fimmu.2018.00660. eCollection 2018.

11.

LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model.

Tsukahara R, Yamamoto S, Yoshikawa K, Gotoh M, Tsukahara T, Neyama H, Ishii S, Akahoshi N, Yanagida K, Sumida H, Araki M, Araki K, Yamamura KI, Murakami-Murofushi K, Ueda H.

J Pharmacol Sci. 2018 Feb;136(2):93-96. doi: 10.1016/j.jphs.2018.01.001. Epub 2018 Feb 2.

12.

Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon.

Saigusa R, Asano Y, Yamashita T, Takahashi T, Nakamura K, Miura S, Ichimura Y, Toyama T, Taniguchi T, Sumida H, Tamaki Z, Miyazaki M, Yoshizaki A, Sato S.

J Dermatol Sci. 2018 Mar;89(3):282-289. doi: 10.1016/j.jdermsci.2017.12.005. Epub 2017 Dec 16.

PMID:
29279288
13.

GPR55 regulates intraepithelial lymphocyte migration dynamics and susceptibility to intestinal damage.

Sumida H, Lu E, Chen H, Yang Q, Mackie K, Cyster JG.

Sci Immunol. 2017 Dec 8;2(18). pii: eaao1135. doi: 10.1126/sciimmunol.aao1135.

14.

Novel Imaging of Hypoglycemia-induced Myocardial Abnormality by Cardiac Magnetic Resonance T1-mapping.

Nakade T, Sumida H, Katahira K, Nishida K.

Intern Med. 2017 Dec 15;56(24):3399-3400. doi: 10.2169/internalmedicine.8889-17. Epub 2017 Oct 11. No abstract available.

15.

Isolated Right Ventricular Stress (Takotsubo) Cardiomyopathy.

Sumida H, Morihisa K, Katahira K, Sugiyama S, Kishi T, Oshima S.

Intern Med. 2017 Aug 15;56(16):2159-2164. doi: 10.2169/internalmedicine.8323-16. Epub 2017 Aug 1.

16.

Pre-procedural peripheral endothelial function is associated with increased serum creatinine following percutaneous coronary procedure in stable patients with a preserved estimated glomerular filtration rate.

Sumida H, Matsuzawa Y, Sugiyama S, Sugamura K, Nozaki T, Akiyama E, Ohba K, Konishi M, Matsubara J, Fujisue K, Maeda H, Kurokawa H, Iwashita S, Ogawa H, Tsujita K.

J Cardiol. 2017 Nov;70(5):461-469. doi: 10.1016/j.jjcc.2017.03.004. Epub 2017 Apr 11.

17.

A case of systemic sclerosis with linear scleroderma developing after fracture surgery.

Saigusa R, Asano Y, Yamashita T, Sumida H, Miyazaki M, Sato S.

Eur J Dermatol. 2017 Apr 1;27(2):200-201. doi: 10.1684/ejd.2016.2956. No abstract available.

PMID:
28251893
18.

Staging laparoscopy for advanced gastric cancer: significance of preoperative clinicopathological factors.

Hosogi H, Shinohara H, Tsunoda S, Hisamori S, Sumida H, Hida K, Obama K, Okabe H, Sakai Y.

Langenbecks Arch Surg. 2017 Feb;402(1):33-39. doi: 10.1007/s00423-016-1536-7. Epub 2016 Nov 29.

PMID:
27900486
19.

Carbonylated proteins exposed to UVA and to blue light generate reactive oxygen species through a type I photosensitizing reaction.

Mizutani T, Sumida H, Sagawa Y, Okano Y, Masaki H.

J Dermatol Sci. 2016 Dec;84(3):314-321. doi: 10.1016/j.jdermsci.2016.09.016. Epub 2016 Sep 28.

PMID:
27743910
20.

Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: Subanalysis of PRECISE-IVUS trial.

Tsujita K, Yamanaga K, Komura N, Sakamoto K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE-IVUS Investigators.

Atherosclerosis. 2016 Aug;251:367-372. doi: 10.1016/j.atherosclerosis.2016.05.025. Epub 2016 May 20.

PMID:
27318866
21.

Synergistic effect of ezetimibe addition on coronary atheroma regression in patients with prior statin therapy: Subanalysis of PRECISE-IVUS trial.

Tsujita K, Yamanaga K, Komura N, Sakamoto K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE-IVUS Investigators.

Eur J Prev Cardiol. 2016 Sep;23(14):1524-8. doi: 10.1177/2047487316655465. Epub 2016 Jun 13.

PMID:
27296705
22.

Discovery of a 2-hydroxyacetophenone derivative as an outstanding linker to enhance potency and β-selectivity of liver X receptor agonist.

Koura M, Yamaguchi Y, Kurobuchi S, Sumida H, Watanabe Y, Enomoto T, Matsuda T, Okuda A, Koshizawa T, Matsumoto Y, Shibuya K.

Bioorg Med Chem. 2016 Aug 15;24(16):3436-46. doi: 10.1016/j.bmc.2016.05.048. Epub 2016 May 24.

PMID:
27283790
23.

Linear scleroderma with prominent multiple lymphadenopathy followed by the development of polymyositis: A case report and review of published work.

Takahashi T, Asano Y, Hirakawa M, Nakamura K, Saigusa R, Aozasa N, Sumida H, Fujita H, Sugaya M, Ohmori A, Shimizu J, Sato S.

J Dermatol. 2016 Oct;43(10):1224-1227. doi: 10.1111/1346-8138.13424. Review.

PMID:
27129435
24.

A case of scleroderma en coup de sabre progressing gradually over 60 years.

Saigusa R, Asano Y, Sumida H, Sato S.

Scand J Rheumatol. 2017 Jan;46(1):83-84. doi: 10.3109/03009742.2016.1158315. Epub 2016 Apr 20. No abstract available.

PMID:
27096565
25.

Crystal structures of (S)-(+)-5-(3-bromo/chloro-4-isopropoxyphen-yl)-5-methyl-imidazolidine-2,4-dione.

Ohba S, Koura M, Sumida H, Shibuya K.

Acta Crystallogr E Crystallogr Commun. 2016 Jan 16;72(Pt 2):184-7. doi: 10.1107/S2056989015023014. eCollection 2016 Feb 1.

26.

Comparison of morphological features in the femur between femoral neck fractures and femoral intertrochanteric fractures.

Yamauchi K, Naofumi M, Sumida H, Fukuta S, Hori H.

Surg Radiol Anat. 2016 Sep;38(7):775-80. doi: 10.1007/s00276-016-1626-9. Epub 2016 Jan 22.

PMID:
26801666
27.

[Human Resource Development in Schientific Society].

Sumida H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2015 Dec;71(12):i. doi: 10.6009/jjrt.2015_JSRT_71.12.i. Japanese. No abstract available.

28.

Stereoselective Synthesis of Z-α,β-Unsaturated Sulfones Using Peterson Reagents.

Ando K, Wada T, Okumura M, Sumida H.

Org Lett. 2015 Dec 18;17(24):6026-9. doi: 10.1021/acs.orglett.5b03008. Epub 2015 Dec 4.

PMID:
26636612
29.

Prognostic Significance of Peripheral Microvascular Endothelial Dysfunction in Heart Failure With Reduced Left Ventricular Ejection Fraction.

Fujisue K, Sugiyama S, Matsuzawa Y, Akiyama E, Sugamura K, Matsubara J, Kurokawa H, Maeda H, Hirata Y, Kusaka H, Yamamoto E, Iwashita S, Sumida H, Sakamoto K, Tsujita K, Kaikita K, Hokimoto S, Matsui K, Ogawa H.

Circ J. 2015;79(12):2623-31. doi: 10.1253/circj.CJ-15-0671. Epub 2015 Oct 21.

30.

Advanced peripheral microvascular endothelial dysfunction and polyvascular disease in patients with high cardiovascular risk.

Maeda H, Sugiyama S, Jinnouchi H, Matsuzawa Y, Fujisue K, Hirata Y, Kurokawa H, Ohba K, Matsubara J, Nozaki T, Konishi M, Akiyama E, Sugamura K, Yamamoto E, Sumida H, Ogawa H.

J Cardiol. 2016 May;67(5):455-62. doi: 10.1016/j.jjcc.2015.07.003. Epub 2015 Sep 4.

31.

Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.

Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE–IVUS Investigators.

J Am Coll Cardiol. 2015 Aug 4;66(5):495-507. doi: 10.1016/j.jacc.2015.05.065.

32.

A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.

Takahashi T, Asano Y, Noda S, Aozasa N, Akamata K, Taniguchi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Tada Y, Sugaya M, Kadono T, Sato S.

Br J Dermatol. 2015 Sep;173(3):681-9. doi: 10.1111/bjd.13779. Epub 2015 Jun 11.

PMID:
25781362
33.

Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.

Saigusa R, Asano Y, Nakamura K, Miura S, Ichimura Y, Takahashi T, Toyama T, Taniguchi T, Noda S, Aozasa N, Akamata K, Sumida H, Miyazaki M, Tamaki Z, Yanaba K, Kuwano Y, Sato S.

J Dermatol. 2015 May;42(5):524-7. doi: 10.1111/1346-8138.12827. Epub 2015 Feb 27.

PMID:
25720827
34.

Telmisartan enhances mitochondrial activity and alters cellular functions in human coronary artery endothelial cells via AMP-activated protein kinase pathway.

Kurokawa H, Sugiyama S, Nozaki T, Sugamura K, Toyama K, Matsubara J, Fujisue K, Ohba K, Maeda H, Konishi M, Akiyama E, Sumida H, Izumiya Y, Yasuda O, Kim-Mitsuyama S, Ogawa H.

Atherosclerosis. 2015 Apr;239(2):375-85. doi: 10.1016/j.atherosclerosis.2015.01.037. Epub 2015 Jan 31.

PMID:
25682036
35.

Decreased plasma levels of active glucagon-like peptide-1 in coronary artery disease.

Akiyama E, Sugiyama S, Matsubara J, Kurokawa H, Konishi M, Nozaki T, Ohba K, Fujisue K, Maeda H, Sakamoto K, Sugamura K, Sumida H, Jinnouchi H, Sakamaki K, Morita S, Kimura K, Umemura S, Ogawa H.

J Am Coll Cardiol. 2015 Feb 24;65(7):754-5. doi: 10.1016/j.jacc.2014.11.043. No abstract available.

36.

Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.

Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Ono T, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE-IVUS study investigators.

J Cardiol. 2015 Oct;66(4):353-8. doi: 10.1016/j.jjcc.2014.12.011. Epub 2015 Jan 7.

37.

Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.

Akamata K, Asano Y, Taniguchi T, Yamashita T, Saigusa R, Nakamura K, Noda S, Aozasa N, Toyama T, Takahashi T, Ichimura Y, Sumida H, Tada Y, Sugaya M, Kadono T, Sato S.

Rheumatology (Oxford). 2015 Jul;54(7):1308-16. doi: 10.1093/rheumatology/keu479. Epub 2014 Dec 23.

PMID:
25539827
38.

Mechanism of cadmium biosorption from aqueous solutions using calcined oyster shells.

Alidoust D, Kawahigashi M, Yoshizawa S, Sumida H, Watanabe M.

J Environ Manage. 2015 Mar 1;150:103-110. doi: 10.1016/j.jenvman.2014.10.032. Epub 2014 Nov 28.

PMID:
25438117
39.

GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment.

Wang X, Sumida H, Cyster JG.

J Exp Med. 2014 Nov 17;211(12):2351-9. doi: 10.1084/jem.20140646. Epub 2014 Oct 27.

40.

CD8(+) aggressive lymphoma in a human T-cell leukaemia virus type-1 carrier.

Saigusa R, Sugaya M, Sunaga S, Sumida H, Suga H, Fujita H, Yoshimii A, Sunaga S, Sato S.

J Dermatol. 2014 May;41(5):443-4. doi: 10.1111/1346-8138.12478. No abstract available.

PMID:
24801919
41.

Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus.

Sumida H, Asano Y, Tamaki Z, Aozasa N, Taniguchi T, Takahashi T, Toyama T, Ichimura Y, Noda S, Akamata K, Miyazaki M, Kuwano Y, Yanaba K, Sato S.

J Dermatol. 2014 May;41(5):418-20. doi: 10.1111/1346-8138.12461.

PMID:
24801917
42.

Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis.

Sumida H, Yanagida K, Kita Y, Abe J, Matsushima K, Nakamura M, Ishii S, Sato S, Shimizu T.

J Immunol. 2014 May 1;192(9):4361-9. doi: 10.4049/jimmunol.1302959. Epub 2014 Mar 24.

43.

Effect of ambrisentan on peripheral circulation in patients with systemic sclerosis.

Sumida H, Asano Y, Hatano M, Aozasa N, Toyama T, Akamata K, Miyazaki M, Taniguchi T, Takahashi T, Ichimura Y, Noda S, Kuwano Y, Yanaba K, Sato S.

Mod Rheumatol. 2016;26(3):454-7. doi: 10.3109/14397595.2014.885377. Epub 2014 Mar 4.

PMID:
24593173
44.

Serum levels of mannose-binding lectin in systemic sclerosis: a possible contribution to the initiation of skin sclerosis in the diffuse cutaneous subtype.

Akamata K, Asano Y, Aozasa N, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Kadono T, Sato S.

Eur J Dermatol. 2014 Jan-Feb;24(1):123-5. doi: 10.1684/ejd.2013.2245. No abstract available.

PMID:
24566202
45.

Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy.

Yanaba K, Asano Y, Akamata K, Noda S, Aozasa N, Taniguchi T, Takahashi T, Toyama T, Ichimura Y, Sumida H, Kuwano Y, Miyazaki M, Sato S.

Int J Rheum Dis. 2016 Jun;19(6):622-7. doi: 10.1111/1756-185X.12288. Epub 2014 Feb 11.

PMID:
24517166
46.

Statins combined with exercise are associated with the increased renal function mediated by high-molecular-weight adiponectin in coronary artery disease patients.

Toyama K, Sugiyama S, Oka H, Iwasaki Y, Sumida H, Tanaka T, Tayama S, Jinnouchi H, Ogawa H.

J Cardiol. 2014 Aug;64(2):91-7. doi: 10.1016/j.jjcc.2013.11.018. Epub 2014 Jan 20.

47.

Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis.

Ichimura Y, Asano Y, Akamata K, Takahashi T, Noda S, Taniguchi T, Toyama T, Aozasa N, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Sato S, Kadono T.

Arch Dermatol Res. 2014 May;306(4):331-8. doi: 10.1007/s00403-013-1431-9. Epub 2013 Nov 29.

PMID:
24292093
48.

Peripheral endothelial function and cardiovascular events in high-risk patients.

Matsuzawa Y, Sugiyama S, Sumida H, Sugamura K, Nozaki T, Ohba K, Matsubara J, Kurokawa H, Fujisue K, Konishi M, Akiyama E, Suzuki H, Nagayoshi Y, Yamamuro M, Sakamoto K, Iwashita S, Jinnouchi H, Taguri M, Morita S, Matsui K, Kimura K, Umemura S, Ogawa H.

J Am Heart Assoc. 2013 Nov 25;2(6):e000426. doi: 10.1161/JAHA.113.000426.

49.

Evaluation of hydrothermal treatment in enhancing rice straw compost stability and maturity.

Nakhshiniev B, Biddinika MK, Gonzales HB, Sumida H, Yoshikawa K.

Bioresour Technol. 2014 Jan;151:306-13. doi: 10.1016/j.biortech.2013.10.083. Epub 2013 Nov 1.

PMID:
24262840
50.

Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis.

Masui Y, Asano Y, Akamata K, Aozasa N, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Sato S, Kadono T.

Rheumatol Int. 2014 Aug;34(8):1165-70. doi: 10.1007/s00296-013-2880-3. Epub 2013 Oct 19.

PMID:
24141536

Supplemental Content

Loading ...
Support Center